Bridging communication gaps between hearing and hearing-impaired individuals is an important challenge in assistive ...
Against the odds, GSK has secured FDA approval for its multiple myeloma therapy Blenrep, three years after it was removed from sale. Anti-BCMA antibody-drug conjugate (ADC) Blenrep (belantamab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback